Cite
HARVARD Citation
Kennedy, N. et al. (2021). Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab. Gut. 70 (5), pp. 865-875. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kennedy, N. et al. (2021). Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab. Gut. 70 (5), pp. 865-875. [Online].